MoneyWorks4Me

Hikal - Quaterly Results

14 Feb 2022 Evaluate
A fair growth of 11.06% in the revenue at Rs. 5145.30 millions was reported in the December 2021 quarter as compared to Rs. 4632.90 millions during year-ago period.Profit saw a slight increase of 12.21%to Rs. 452.00  millions from Rs. 402.80 millions.OP of the company witnessed a marginal growth to 934.80 millions from 918.40 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 5145.30 4632.90 11.06 14403.70 11879.80 21.25 17204.40 15072.60 14.14
Other Income 5.70 5.20 9.62 46.20 21.10 118.96 49.80 37.00 34.59
PBIDT 934.80 918.40 1.79 2841.40 2157.40 31.70 3278.70 2768.50 18.43
Interest 71.80 80.50 -10.81 231.30 262.30 -11.82 362.00 524.20 -30.94
PBDT 863.00 837.90 3.00 2610.10 1895.10 37.73 2916.70 2090.30 39.53
Depreciation 246.80 218.10 13.16 714.40 636.90 12.17 852.40 824.60 3.37
PBT 616.20 619.80 -0.58 1895.70 1258.20 50.67 2064.30 1265.70 63.10
TAX 164.20 217.00 -24.33 498.20 435.90 14.29 732.80 421.40 73.90
Deferred Tax -5.20 -10.20 -49.02 -20.30 -16.90 20.12 -62.70 74.40 -184.27
PAT 452.00 402.80 12.21 1397.50 822.30 69.95 1331.50 844.30 57.70
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 18.17 19.82 -8.35 19.73 18.16 8.63 19.06 18.37 3.75
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..